Mobile Menu

Search Results

Search results for: Industry

Why Death-By-Webinar Will Soon Become a Real Thing (And What to Do About It)

We’re now deep into lockdown, with perhaps some light at the end of the tunnel regarding some sort of return […]

How to Evaluate New Webinar Partnerships

Recent events have seen many life sciences companies turn towards digital platforms, particularly webinars, in an effort to replace the […]

3 Major Forces Re-Shaping the Business Landscape Due to COVID-19

The business impact of COVID-19 is proving to be significant. The post-COVID-19 world is going to look very different to […]

How to respond to the threat of COVID-19: to pivot or not to pivot?

During the difficult times of the coronavirus, it can be hard for businesses to make a strategy for their survival. […]

Video Mathai Mammen: Active Disruption in Pharma

The pharmaceutical industry is undergoing a big change. The industry is going through a big phase due to disruptive technologies. […]

Privacy Policy

We value and respect you as a visitor to our website, and consumer of our services. In turn, we take […]

Genetics Unzipped Podcast: Involving Patients in Genomics Research

“Nothing about me without me!” is the rallying cry for patient involvement in research. In the latest episode of Genetics […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

“Our geneticist could only find three published articles about the GRIN1 gene at the time” – Interview with Jillian Hastings Ward, Chair of the Participant Panel at Genomics England

Jillian Hastings Ward is Chair of the Participant Panel at Genomics England. The Panel acts as an advisory body to the Genomics England board to ensure that the data collected by the 100,000 Genomes Project is being used for the best interests of the participants.

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.